RLMD DCF Valuation - Relmada Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 7.04 USD -2.36% Market Closed

Market Cap: $738.4m

	Relmada Therapeutics Inc NASDAQ:RLMD	US
	Extreme Networks Inc NASDAQ:EXTR	US
	Repay Holdings Corp NASDAQ:RPAY	US
L	L3harris Technologies Inc F:HRS	US
	Aptiv PLC NYSE:APTV	IE
	Synnex Technology International Corp TWSE:2347	TW
	Spotify Technology SA NYSE:SPOT	LU
	Sika AG F:SIKA	CH
M	Mitsubishi Corp XMUN:MBI	JP
	Wayfair Inc NYSE:W	US
	Charter Communications Inc NASDAQ:CHTR	US
V	Vector Group Ltd SWB:VGR	US
	S&T Bancorp Inc NASDAQ:STBA	US
	Globe Life Inc NYSE:GL	US
	Novartis AG SIX:NOVN	CH
T	Toshiba Corp XBER:TSE1	JP
	Arhaus Inc NASDAQ:ARHS	US

RLMD's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.